News
Iterum Therapeutics has become the first drugmaker to bring an oral antibiotic in the penem class to market in the US, ...
Mindler has taken ownership of the UK company, which has been providing digitally delivered talking therapies to the NHS for ...
"We are, of course, disappointed by the FDA's decision to not approve vatiquinone," said Matthew Klein, PTC's chief executive ...
Among the plans will be greater first-line use of SGLT-2 inhibitors or 'gliflozin' drugs, which are mainly used second-line ...
The decision to demerge the CSL Seqirus business into a separate ASX-listed company will allow it to "set an independent ...
Shares in Viking Therapeutics have lost more than 40% of their value after it reported phase 2 results that showed that its ...
In the world of consumer marketing, people-based data has become the gold standard. Demographics are just the starting point. Layered on top are deep behavioural insights into what people buy, browse, ...
And while pharma marketing agencies are embracing AI like everyone else, most are using AI tools on a case-by-case basis to tackle one or more of those areas. But what if an agency were to redesign ...
Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.
Guaranteed domain ownership: The first to pre-register a specific .med domain will be guaranteed to secure it at launch. Go ...
Novo Nordisk has reduced the price of its two semaglutide-based therapies – Ozempic for diabetes and Wegovy for obesity – to ...
According to Palo Alto, California-based Atropos, its researchers have already come up with an initial AI model that has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results